ERNA
Price:
$1.31
Market Cap:
$10.28M
Ernexa Therapeutics Inc., a preclinical-stage company, develops induces derived mesenchymal stem cells (iMSC) therapies for the treatment of solid tumors and autoimmune disease. The company's lead product is ERNA-101, an allogenic pro-inflammatory cytokine (IL-7/IL-15) secreting iMSC for the treatment of ovarian cancer; and ERNA-102, an anti-inflammatory cytokine (IL-10) secreting iMSC for the treatment of rheumatoid arthritis. It has a license agreement with Factor Bioscience Limited. The company was formerly known as Eterna Therapeutics Inc. and changed its name to Ernexa Therapeutics in March 2025. Ernexa Therapeutics Inc. was founded in 2018 and is based in Cambridge, Massachusetts.
Industry
Biotechnology
IPO Date
1991-08-29
Stock Exchange
NASDAQ
Ticker
ERNA
According to Ernexa Therapeutics Inc.’s latest financial reports and current stock price. The company's current ROE is -1949.32%. This represents a change of 2.45% compared to the average of -76.57% of the last 4 quarters.
The mean historical ROE of Ernexa Therapeutics Inc. over the last ten years is -443.89%. The current -1949.32% ROE has changed 339.14% with respect to the historical average. Over the past ten years (40 quarters), ERNA's ROE was at its highest in in the March 2021 quarter at 400.39%. The ROE was at its lowest in in the September 2021 quarter at -659.92%.
Average
-443.89%
Median
-129.82%
Minimum
-2618.40%
Maximum
155.45%
Discovering the peaks and valleys of Ernexa Therapeutics Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 973.82%
Maximum Annual ROE = 155.45%
Minimum Annual Increase = -486.62%
Minimum Annual ROE = -2618.40%
| Year | ROE | Change |
|---|---|---|
| 2024 | -2618.40% | 169.84% |
| 2023 | -970.35% | 377.97% |
| 2022 | -203.01% | -57.67% |
| 2021 | -479.56% | -408.49% |
| 2020 | 155.45% | -486.62% |
| 2019 | -40.21% | 973.82% |
| 2018 | -3.74% | -80.75% |
| 2017 | -19.45% | -72.92% |
| 2016 | -71.85% | -61.74% |
The current ROE of Ernexa Therapeutics Inc. (ERNA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-1263.92%
5-year avg
-823.17%
10-year avg
-443.89%
Ernexa Therapeutics Inc.’s ROE is less than Adaptimmune Therapeutics plc (4.10%), less than MapLight Therapeutics, Inc. (0%), greater than Lunai Bioworks Inc. (-288.06%), greater than ProMIS Neurosciences, Inc. (-336.93%), greater than Dogwood Therapeutics, Inc. (-66.07%), greater than BiomX Inc. (-190.95%), less than Moleculin Biotech, Inc. (589.47%), less than AEON Biopharma, Inc. (0.02%), greater than OSR Holdings, Inc. (-22.68%), less than Aethlon Medical, Inc. (-1.46%),
| Company | ROE | Market cap |
|---|---|---|
| 4.10% | $75.16M | |
| 0% | $14.48M | |
| -288.06% | $23.14M | |
| -336.93% | $9.98M | |
| -66.07% | $11.73M | |
| -190.95% | $7.28M | |
| 589.47% | $9.32M | |
| 0.02% | $8.72M | |
| -22.68% | $17.76M | |
| -1.46% | $10.47M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Ernexa Therapeutics Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Ernexa Therapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Ernexa Therapeutics Inc.'s ROE?
How is the ROE calculated for Ernexa Therapeutics Inc. (ERNA)?
What is the highest ROE for Ernexa Therapeutics Inc. (ERNA)?
What is the 3-year average ROE for Ernexa Therapeutics Inc. (ERNA)?
What is the 5-year average ROE for Ernexa Therapeutics Inc. (ERNA)?
How does the current ROE for Ernexa Therapeutics Inc. (ERNA) compare to its historical average?